Groups, clinical data, and samples used in the study
| Groups . | Sex . | Status . | . | ||
|---|---|---|---|---|---|
| Male, no. . | Female, no. . | Dead, no. . | Alive, no. . | Frozen LN samples, no. . | |
| 1. FL | 36 | 27 | 48 | 15 | 63 |
| 2. DLBCL | 15 | 10 | 22 | 3 | 25 |
| 3. FL(F) pre-t-DLBCL(F) | 2 | 2 | 4 | 0 | 4 |
| 4. DLBCL(F) post-FL(F) | 2 | 2 | 4 | 0 | 4 |
| 5. RLN | 5 | 5 | 0 | 5 | 10 |
| Totals | 60 | 46 | 78 | 23 | 106 |
| Groups . | Sex . | Status . | . | ||
|---|---|---|---|---|---|
| Male, no. . | Female, no. . | Dead, no. . | Alive, no. . | Frozen LN samples, no. . | |
| 1. FL | 36 | 27 | 48 | 15 | 63 |
| 2. DLBCL | 15 | 10 | 22 | 3 | 25 |
| 3. FL(F) pre-t-DLBCL(F) | 2 | 2 | 4 | 0 | 4 |
| 4. DLBCL(F) post-FL(F) | 2 | 2 | 4 | 0 | 4 |
| 5. RLN | 5 | 5 | 0 | 5 | 10 |
| Totals | 60 | 46 | 78 | 23 | 106 |
Details of the composition of each group are detailed in “Clinical samples.” F indicates frozen tissue; t, transformed.